Neurotoxicity mechanisms of thioether ecstasy metabolites

J P Capela1, C Macedo, P S Branco

  • 1REQUIMTE (Rede de Química e Tecnologia), Toxicology Department, Faculty of Pharmacy, University of Porto, Rua Aníbal Cunha, 164, 4099-030 Porto, Portugal. joaocapela@ff.up.pt

Neuroscience
|May 1, 2007
PubMed

Insights

Thioether metabolites of 3,4-Methylenedioxymethamphetamine (MDMA) are potent neurotoxins, causing delayed neuronal death and oxidative stress. N-acetylcysteine (NAC) protected against these toxic effects, suggesting its therapeutic potential.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • 3,4-Methylenedioxymethamphetamine (MDMA), or ecstasy, is a recreational drug known for neurotoxic effects.
  • MDMA metabolism produces compounds like 3,4-methylenedioxyamphetamine (MDA), N-methyl-alpha-methyldopamine (N-Me-alpha-MeDA), and alpha-methyldopamine (alpha-MeDA).
  • These metabolites can form ortho-quinones, which conjugate with glutathione (GSH) and are further metabolized to N-acetylcysteine (NAC) adducts.

Purpose of the Study:

  • To evaluate the neurotoxicity of nine synthesized MDMA metabolites, including N-Me-alpha-MeDA, alpha-MeDA, and their GSH and NAC adducts.
  • To investigate the mechanisms underlying MDMA metabolite-induced neurotoxicity under normal and hyperthermic conditions.
  • To assess the protective effects of NAC against MDMA metabolite neurotoxicity.

Main Methods:

  • Exposure of rat cortical neuronal cultures to synthesized MDMA metabolites for 6 hours.
  • Assessment of neuronal death, caspase 3 activation, reactive species production, intracellular GSH levels, and protein-bound quinones.
  • Comparison of neurotoxicity under normal (36.5°C) and hyperthermic (40°C) conditions.

Main Results:

  • Thioether MDMA metabolites (GSH and NAC adducts) demonstrated significant neurotoxicity, exceeding that of their parent catechols (N-Me-alpha-MeDA, alpha-MeDA).
  • N-Me-alpha-MeDA and alpha-MeDA were more neurotoxic than MDMA.
  • GSH and NAC conjugates induced delayed neuronal death, caspase 3 activation (earlier in hyperthermia), increased reactive species, depleted GSH, and increased protein-bound quinones.
  • NAC administration prevented MDMA metabolite-induced neuronal death and oxidative stress.

Conclusions:

  • Thioether MDMA metabolites are potent neurotoxins contributing significantly to ecstasy-induced neurotoxicity.
  • Hyperthermia exacerbates the neurotoxic effects of these metabolites.
  • NAC exhibits neuroprotective properties against MDMA metabolite toxicity, highlighting its potential therapeutic role.

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...